Thursday, May 12, 2022
  • About
  • Privacy Policy
  • Editorial Principles
  • Why to trust us
  • Contact
Scoop Nova
  • Home
  • Business
  • Technology
  • Scandals
  • Politics
No Result
View All Result
Scoop Nova
  • Home
  • Business
  • Technology
  • Scandals
  • Politics
No Result
View All Result
Scoop Nova
No Result
View All Result
Home Business

NIH licenses key Covid vaccine technology to WHO so other countries can develop shots

admin by admin
May 12, 2022
in Business
0
NIH licenses key Covid vaccine technology to WHO so other countries can develop shots
585
SHARES
3.2k
VIEWS
Share on FacebookShare on Twitter

You might also like

Peloton (PTON) fiscal Q3 2021 losses mount

Inside the $23.5 million house that may break local California record

Andy Warhol’s ‘Marilyn’ sells for $195 million, sets American record

U.S. President Joe Biden spoke in a speech at the South Court Auditorium at the Eisenhower Executive Office Building in the White House, Washington, on November 3, 2021, with coronavirus disease (COVID-) for children aged 5 to 11 years. 19) I would like to say about the approval of the vaccine.

Evelyn Hoxtine | Reuters

President Joe Biden said Thursday that the United States has licensed the key technologies used in the current Covid-19 vaccine to the World Health Organization. This will allow manufacturers around the world to work with the World Health Organization to develop their own injections for the virus.

National Institutes of Health Stabilized peplomer protein technology According to Biden, in the WHO and UN drug patent pools.

Peplomers are a component of vaccines that provoke an immune response and encourage the body to fight the virus. NIH technology keeps proteins in a structure that can generate a stronger immune response. WHO and Medicines Patent Pool can now sublicense the technology to generic manufacturers around the world.

“We are making access to US government-owned health technologies, including the stabilized peplomer used in many Covid-19 vaccines,” Biden said.

The decision to share vaccine technology precedes the virtual Global Covid-19 Summit co-sponsored by the United States on Thursday. Peplomer technology is very important, but vaccines also contain other ingredients. Some of them are company-specific.

WHO said in a statement Thursday that the license would give people in low- and middle-income countries access to important technologies and help end the pandemic.

The technology behind the Covid vaccine has become a major issue throughout the pandemic. WHO has repeatedly called on vaccine makers to share their know-how, Pfizer When Moderna Refused to license the technology behind the shot to Medicines Patent Pool, one of the United Nations public health agencies like WHO. However, Moderna has not enforced patents in 92 poor countries. Pfizer does not share the technology, but provides the US government with a billion doses for donations to poor countries.

WHO has traveled around vaccine makers to establish a manufacturing hub in South Africa to produce vaccines based on the messenger RNA technology used by Pfizer and Moderna in Shots. South African scientists are making a general copy of Moderna’s vaccine based on publicly available information because biotechnology companies have not enforced their patents.

WHO Executive Secretary Tedros Adhanom Ghebreyesus called on Moderna shareholders to support a resolution calling for a third-party investigation into the feasibility of technology transfer at the annual meeting of biotechnology companies.

“Moderna can work with us to submit a Habu vaccine for approval at least a year earlier, which saves lives, reduces the risk of variants, and reduces the economic damage to the pandemic. You can, “says Tedros.

The United States has also donated an additional $ 200 million to the World Bank’s Pandemic Countermeasures Fund, a total of $ 450 million, and an additional $ 20 million through the United States International Development Agency for Covid testing in eight countries. We support the development of anti-virus treatment. The White House also said it would expand vaccine donations through Pfizer to include booster effects and injections for children.

The donation is far from the $ 5 billion that the White House has demanded from Congress to support vaccination around the world. Congress was unable to pass Biden’s broader demand for $ 22.5 billion in Covid funding because of opposition from Republicans who oppose using much of it.

Senators reached a $ 10 billion Covid funding agreement in April, which did not include funding for a global vaccination campaign. The Republican Party has a Senate of $ 10 billion in a dispute over the decision by the Centers for Disease Control and Prevention to end the controversial policy of returning asylum seekers on the national border to Mexico as a public health measure. Blocked from passing through.

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid Pandemic.

Tags: BiotechnologyBiotechnology and medicineBreaking News: BusinessBusiness newscoronaviruscountriesCoviddevelopEpidemicHealthcare industrykeylicensesModerna IncNIHOutbreak of illnesspandemicPfizer Japan IncpoliticsshotstechnologyUS economyvaccinework
Previous Post

Alphabet CEO Sundar Pichai: CNBC interview

admin

admin

Related Posts

Peloton (PTON) fiscal Q3 2021 losses mount
Business

Peloton (PTON) fiscal Q3 2021 losses mount

by admin
May 10, 2022
Inside the $23.5 million house that may break local California record
Business

Inside the $23.5 million house that may break local California record

by admin
May 10, 2022
Andy Warhol’s ‘Marilyn’ sells for $195 million, sets American record
Business

Andy Warhol’s ‘Marilyn’ sells for $195 million, sets American record

by admin
May 10, 2022
U.S. will limit Covid vaccines to high-risk people this fall if Congress doesn’t approve more funding
Business

U.S. will limit Covid vaccines to high-risk people this fall if Congress doesn’t approve more funding

by admin
May 9, 2022
5 things to know before the stock market opens Monday, May 9
Business

5 things to know before the stock market opens Monday, May 9

by admin
May 9, 2022

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

White House focused on imposing Russia sanctions, Biden security advisor Sullivan says

White House focused on imposing Russia sanctions, Biden security advisor Sullivan says

April 14, 2022
Scotland’s Budget Promises a Record Amount of Money to Combat Climate Change and Poverty

Scotland’s Budget Promises a Record Amount of Money to Combat Climate Change and Poverty

February 1, 2022

Categories

  • Business
  • Politics
  • Scandals
  • Technology
  • Uncategorized

Don't miss it

NIH licenses key Covid vaccine technology to WHO so other countries can develop shots
Business

NIH licenses key Covid vaccine technology to WHO so other countries can develop shots

May 12, 2022
Alphabet CEO Sundar Pichai: CNBC interview
Technology

Alphabet CEO Sundar Pichai: CNBC interview

May 12, 2022
Biden will host ASEAN summit at the White House
Politics

Biden will host ASEAN summit at the White House

May 12, 2022
Peloton (PTON) fiscal Q3 2021 losses mount
Business

Peloton (PTON) fiscal Q3 2021 losses mount

May 10, 2022
Amazon fires two employees tied to Staten Island union effort
Technology

Amazon fires two employees tied to Staten Island union effort

May 10, 2022
Biden signs Ukraine lend-lease military aid bill amid Russia invasion
Politics

Biden signs Ukraine lend-lease military aid bill amid Russia invasion

May 10, 2022
Scoop Nova

Scoop Nova is the only worldwide news organization with a European perspective, and it’s where the rest of the world goes to hear what the World has to say.

Categories

  • Business
  • Technology
  • Scandals
  • Politics

Quick Links

  • About Scoop Nova
  • Contact us
  • Editorial Principles
  • Why to trust us
  • Privacy Policy
  • Sitemap

Recent News

NIH licenses key Covid vaccine technology to WHO so other countries can develop shots

NIH licenses key Covid vaccine technology to WHO so other countries can develop shots

May 12, 2022
Alphabet CEO Sundar Pichai: CNBC interview

Alphabet CEO Sundar Pichai: CNBC interview

May 12, 2022

© Copyright 2022 ! All rights are reserved by scoopnova.com

No Result
View All Result
  • Home
  • Business
  • Technology
  • Scandals
  • Politics

© Copyright 2022 ! All rights are reserved by scoopnova.com